Protagonist Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTGX and other ETFs, options, and stocks.About PTGX
Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943.
PTGX Key Statistics
Stock Snapshot
The current Protagonist Therapeutics(PTGX) stock price is $84.54, with a market capitalization of 5.29B. The stock trades at a price-to-earnings (P/E) ratio of 126.70.
On 2026-01-14, Protagonist Therapeutics(PTGX) stock traded between a low of $80.47 and a high of $85.12. Shares are currently priced at $84.54, which is +5.1% above the low and -0.7% below the high.
Protagonist Therapeutics(PTGX) shares are trading with a volume of 403.81K, against a daily average of 870.16K.
In the last year, Protagonist Therapeutics(PTGX) shares hit a 52-week high of $96.54 and a 52-week low of $33.70.
In the last year, Protagonist Therapeutics(PTGX) shares hit a 52-week high of $96.54 and a 52-week low of $33.70.
PTGX News
Claim 70% Off TipRanks Premium Protagonist Therapeutics ( (PTGX) ) has issued an update. On January 12, 2026, Protagonist Therapeutics released an updated cor...